- Home
- NVTS vs OLMA Comparison
NVTS vs OLMA Comparison
Compare NVTS & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVTS
- OLMA
- Stock Information
- Founded
- NVTS 2014
- OLMA 2006
- Country
- NVTS United States
- OLMA United States
- Employees
- NVTS N/A
- OLMA N/A
- Industry
- NVTS Semiconductors
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- NVTS Technology
- OLMA Health Care
- Exchange
- NVTS Nasdaq
- OLMA Nasdaq
- Market Cap
- NVTS 473.3M
- OLMA 525.7M
- IPO Year
- NVTS N/A
- OLMA 2020
- Fundamental
- Price
- NVTS $1.78
- OLMA $9.43
- Analyst Decision
- NVTS Buy
- OLMA Strong Buy
- Analyst Count
- NVTS 8
- OLMA 5
- Target Price
- NVTS $4.75
- OLMA $27.00
- AVG Volume (30 Days)
- NVTS 3.3M
- OLMA 417.7K
- Earning Date
- NVTS 11-04-2024
- OLMA 11-12-2024
- Dividend Yield
- NVTS N/A
- OLMA N/A
- EPS Growth
- NVTS N/A
- OLMA N/A
- EPS
- NVTS N/A
- OLMA N/A
- Revenue
- NVTS $91,381,000.00
- OLMA N/A
- Revenue This Year
- NVTS $8.34
- OLMA N/A
- Revenue Next Year
- NVTS $5.50
- OLMA N/A
- P/E Ratio
- NVTS N/A
- OLMA N/A
- Revenue Growth
- NVTS 38.99
- OLMA N/A
- 52 Week Low
- NVTS $1.76
- OLMA $8.51
- 52 Week High
- NVTS $8.44
- OLMA $17.10
- Technical
- Relative Strength Index (RSI)
- NVTS 30.33
- OLMA 28.00
- Support Level
- NVTS $1.77
- OLMA $11.46
- Resistance Level
- NVTS $1.93
- OLMA $13.06
- Average True Range (ATR)
- NVTS 0.17
- OLMA 0.80
- MACD
- NVTS -0.08
- OLMA -0.23
- Stochastic Oscillator
- NVTS 1.75
- OLMA 0.00
About NVTS Navitas Semiconductor Corporation
Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.